Determinants of mortality for adults with cystic fibrosis admitted in Intensive Care Unit: A multicenter study

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Texereau, Joëlle ^a,b,c,k,l   Jamal, Dany ^a   Choukroun, Gérald ^a,b,k,l   Burgel, Pierre Régis ^a,c   Diehl, Jean Luc ^c,d   Rabbat, Antoine ^c,e   Loirat, Philippe ^f   Parrot, Antoine ^g,h   Duguet, Alexandre ^g,i   Coste, Joël ^c,j   Dusser, Daniel ^a,c   Hubert, Dominique ^a,c   Mira, Jean Paul ^a,b,c,k,l  

^a Hôpital Cochin ^*  (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e HÔTEL DIEU   (France)

^f FOCH HOSPITAL   (France)

^g SORBONNE UNIVERSITÉ   (France)

^h HÔPITAL TENON   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^k INSERM   (France)

^l CNRS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ADULT; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; ASSISTED VENTILATION; CLINICAL ARTICLE; CLINICAL PRACTICE; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LUNG INFECTION; LUNG TRANSPLANTATION; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SELECTION; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; SURVIVAL RATE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; EPIDEMIOLOGY; FRANCE; INTENSIVE CARE; MULTICENTER STUDY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; SURVIVAL;

ADULT; CYSTIC FIBROSIS; FEMALE; FRANCE; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 33644943441     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-14     Document Type: Article

References (26)

1. Rowe SM, Miller S, Sorscher EJ: Cystic fibrosis. N Engl J Med 2005, 352:1992-2001.
2. Yankaskas JR, Marshall BC, Sufian B, Simon RH, Rodman D: Cystic fibrosis adult care: consensus conference report. Chest 2004, 125:1S-39S.
3. Cystic Fibrosis Foundation: Patient Registry 2003 Annual Report Bethesda, Maryland. Cystic Fibrosis Foundation; 2004.
4. Observatoire National de la Mucoviscidose: rapport sur la situation de la mucoviscidose en France en 2003. Vaincre la Mucoviscidose Institut National d'Etudes Démographiques; 2005.
5. Davis PB, di Sant'Agnese PA: Assisted ventilation for patients with cystic fibrosis. Jama 1978, 239:1851-4.
6. Sood N, Paradowski LJ, Yankaskas JR: Outcomes of intensive care unit care in adults with cystic fibrosis. Am J Respir Crit Care Med 2001, 163:335-8.
7. Vedam H, Moriarty C, Torzillo PJ, McWilliam D, Bye PT: Improved outcomes of patients with cystic fibrosis admitted to the intensive care unit. J Cyst Fibros 2004, 3:8-14.
8. Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, Simonneau G, Benito S, Gasparetto A, Lemaire F, et al.: Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995, 333:817-22.
9. Girou E, Brun-Buisson C, Taille S, Lemaire F, Brochard L: Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. Jama 2003, 290:2985-91.
10. Zielenski J: Genotype and phenotype in cystic fibrosis. Respiration 2000, 67:117-33.
11. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. Jama 1993, 270:2957-63.
12. Ellaffi M, Vinsonneau C, Coste J, Hubert D, Burgel PR, Dhainaut JF, Dusser D: One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:158-64.
13. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B: Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168:165-72.
14. Martin TJ, Hovis JD, Costantino JP, Bierman MI, Donahoe MP, Rogers RM, Kreit JW, Sciurba JC, Stiller RA, Sanders MH: A randomized, prospective evaluation of noninvasive ventilation for acute respiratory failure. Am J Respir Crit Care Med 2000, 161:807-13.
15. Berlinski A, Fan LL, Kozinetz CA, Oermann CM: Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study. Pediatr Pulmonol 2002, 34:297-303.
16. Bartz RR, Love RB, Leverson GE, Will LR, Welter DL, Meyer KC: Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis. J Heart Lung Transplant 2003, 22:433-8.
17. Kerem E, Reisman J, Corey M, Canny GJ, Levison H: Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992, 326:1187-91.
18. Liou TG, Adler FR, Fitzsimmons SC, Cahill BC, Hibbs JR, Marshall BC: Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001, 153:345-52.
19. Aurora P, Wade A, Whitmore P, Whitehead B: A model for predicting life expectancy of children with cystic fibrosis. Eur Respir J 2000, 16:1056-60.
20. Hayllar KM, Williams SG, Wise AE, Pouria S, Lombard M, Hodson ME, Westaby D: A prognostic model for the prediction of survival in cystic fibrosis. Thorax 1997, 52:313-7.
21. Liou TG, Adler FR, Huang D: Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 2005, 171:1053-9.
22. International guidelines for the selection of lung transplant candidates: The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). Am J Respir Crit Care Med 1998, 158:335-9.
23. Yankaskas JR, Mallory GB Jr: Lung transplantation in cystic fibrosis: consensus conference statement. Chest 1998, 113:217-26.
24. Milla CE, Warwick WJ: Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998, 113:1230-4.
25. Rosenbluth DB, Wilson K, Ferkol T, Schuster DP: Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. Chest 2004, 126:412-9.
26. Oikonomou A, Manavis J, Karagianni P, Tsanakas J, Wells AU, Hansell DM, Papadopoulou F, Efremidis SC: Loss of FEV1 in cystic fibrosis: correlation with HRCT features. Eur Radiol 2002, 12:2229-35.